Efficacy of rociletinib (CO-1686) in centrally confirmed T790M-positive and T790M-negative non-small cell lung cancer (NSCLC) patients (Pts) Meeting Abstract
| Authors: | Sequist, L. V.; Goldman, J. W.; Wakelee, H.; Camidge, D. R.; Gadgeel, S.; Yu, H. A.; Varga, A.; Solomon, B.; Oxnard, G. R.; Ou, S. H. I.; Papadimitrakopoulou, V.; Liu, S. V.; Reckamp, K. L.; Spira, A. I.; Despain, D.; Karlovich, C. A.; Yurasov, S.; Soria, J. C. |
| Abstract Title: | Efficacy of rociletinib (CO-1686) in centrally confirmed T790M-positive and T790M-negative non-small cell lung cancer (NSCLC) patients (Pts) |
| Meeting Title: | 32. Deutscher Krebskongress Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ (DKK 2016) |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 39 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2016 Feb 24-27 |
| Meeting Location: | Berlin, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2016-02-01 |
| Start Page: | 121 |
| Language: | English |
| ACCESSION: | WOS:000371353700392 |
| PROVIDER: | wos |
| PUBMED: | 26905290 |
| DOI: | 10.1159/000444354 |
| Notes: | Meeting Abstract: ID 0443 -- [32nd German Cancer Congress – Cancer Medicine Today: Preventive, Personalized, Precise and Participative] -- Source: Wos |
